These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D Gowrishankar R; Gresch PJ; Davis GL; Katamish RM; Riele JR; Stewart AM; Vaughan RA; Hahn MK; Blakely RD J Neurosci; 2018 Jun; 38(23):5302-5312. PubMed ID: 29739866 [TBL] [Abstract][Full Text] [Related]
5. Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model. Dai H; Jackson CR; Davis GL; Blakely RD; McMahon DG J Neurodev Disord; 2017 Dec; 9(1):38. PubMed ID: 29281965 [TBL] [Abstract][Full Text] [Related]
9. Towards trans-diagnostic mechanisms in psychiatry: neurobehavioral profile of rats with a loss-of-function point mutation in the dopamine transporter gene. Vengeliene V; Bespalov A; Roßmanith M; Horschitz S; Berger S; Relo AL; Noori HR; Schneider P; Enkel T; Bartsch D; Schneider M; Behl B; Hansson AC; Schloss P; Spanagel R Dis Model Mech; 2017 Apr; 10(4):451-461. PubMed ID: 28167616 [TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes. Herborg F; Andreassen TF; Berlin F; Loland CJ; Gether U J Biol Chem; 2018 May; 293(19):7250-7262. PubMed ID: 29559554 [TBL] [Abstract][Full Text] [Related]
11. The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent Mechanism. Bermingham DP; Hardaway JA; Refai O; Marks CR; Snider SL; Sturgeon SM; Spencer WC; Colbran RJ; Miller DM; Blakely RD J Neurosci; 2017 Sep; 37(38):9288-9304. PubMed ID: 28842414 [TBL] [Abstract][Full Text] [Related]
12. Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies. Costa A; Riedel M; Müller U; Möller HJ; Ettinger U Synapse; 2011 Oct; 65(10):998-1005. PubMed ID: 21404331 [TBL] [Abstract][Full Text] [Related]
13. ADHD and the dopamine transporter: are there reasons to pay attention? Mazei-Robinson MS; Blakely RD Handb Exp Pharmacol; 2006; (175):373-415. PubMed ID: 16722244 [TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter is enriched in filopodia and induces filopodia formation. Caltagarone J; Ma S; Sorkin A Mol Cell Neurosci; 2015 Sep; 68():120-30. PubMed ID: 25936602 [TBL] [Abstract][Full Text] [Related]
17. The structure and function of the dopamine transporter and its role in CNS diseases. McHugh PC; Buckley DA Vitam Horm; 2015; 98():339-69. PubMed ID: 25817874 [TBL] [Abstract][Full Text] [Related]
18. Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice. Davis GL; Stewart A; Stanwood GD; Gowrishankar R; Hahn MK; Blakely RD Behav Brain Res; 2018 Jan; 337():61-69. PubMed ID: 28964912 [TBL] [Abstract][Full Text] [Related]
19. Cis-acting elements responsible for dopaminergic neuron-specific expression of zebrafish slc6a3 (dopamine transporter) in vivo are located remote from the transcriptional start site. Bai Q; Burton EA Neuroscience; 2009 Dec; 164(3):1138-51. PubMed ID: 19755139 [TBL] [Abstract][Full Text] [Related]
20. Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease. Lohr KM; Masoud ST; Salahpour A; Miller GW Eur J Neurosci; 2017 Jan; 45(1):20-33. PubMed ID: 27520881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]